Skip to main content
ALTHealthcare

Altimmune Inc (ALT) Insider Trading

In the last 90 days, 1 Altimmune Inc (ALT) insider reported 1 open-market purchase totaling $44,250 and no sales. The most recent open-market purchase was reported on Aug 13, 2026. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
1
90-day purchase value
$44,250
Corporate buyers
1
Latest transaction
Aug 13, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 13, 2026Jerome Benedict DursoPresident and CEOOpen Market Purchase15,000$2.95$44,250

Common questions

ALT insider trading FAQ

Are ALT insiders buying or selling?
Over the last 90 days, ALT insiders were net buyers, reporting $44,250 of open-market purchases and $0.00 of sales.
When was the last ALT insider purchase?
The most recent open-market purchase of Altimmune Inc stock by an insider was reported on Aug 13, 2026, one of 1 purchase in the last 90 days.
Where does ALT insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Altimmune Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.